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 2 
Abstract 
 
Objective: Communicating treatment risks and benefits to patients and their carers is 
central to clinical practice in modern healthcare. We investigated the challenges of 
risk communication by clinicians offering thrombolytic therapy for hyper-acute stroke 
where treatment must be administered rapidly to maximise benefit. 
 
Method: Semi-structured interviews with 13 clinicians from three acute stroke units 
involved in decision making and/or information provision about thrombolysis. We 
report on clinicians’ accounts of communicating risks and benefits to patients and 
carers. Framework analysis was employed.   
 
Results: We identified the major challenges facing clinicians in communicating risk in 
this context i.e. disease complexity, patients’ capacity and time constraints, and 
communicating quality of life after stroke. We found significant variation in the data 
on risks and benefits that clinicians provide and ways these were communicated to 
patients. Clinicians’ communication strategies varied and included practices such as: a 
phased approach to communicating information, being responsive to the patient and 
family and documenting information they gave to patients.  
 
Conclusion: Risk communication about thrombolysis involves complex uncertainties. 
We elucidate the challenges of effective risk communication in a hyper acute setting 
and identify the issues regarding variation in risk communication and the use of less 
effective formats for the communication of numerical risks and benefits. The paper 
identifies good practice such as the phased transfer of information over the care 
pathway, and ways in which clinicians might be supported to overcome challenges. 
This includes standardised risk and benefit information alongside appropriate 
personalisation of risk communication. 
 
Practice Implications: Effective risk communication in emergency settings requires 
presentation of high quality data which is amenable to tailoring to individual patient’s 
circumstances. It necessitates clinical skills development supported by personalised 
risk communication tools.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 1: What is already known about the subject 
There is growing evidence that risk communication using established principles and 
access to patient decision aids facilitate better understanding and more informed 
decision-making. In the complex hyper-acute setting of stroke thrombolysis, Mangset et 
al (2009) have shown that patients have limited perceptions of the risks associated with 
stroke thrombolysis. To date, there has been no reported in depth research with 
clinicians exploring risk communication in this setting. 
 
Section 2: What this study adds 
This study provides results of a qualitative study examining doctors’ reported approaches 
to risk communication about stroke thrombolysis in the complex and challenging setting 
of hyper-acute stroke. Apart from examples of good practice, we found variations 
identified in risk communication among clinicians that might be expected to adversely 
affect understanding by patients and their families. These findings identify the need for 1) 
greater appreciation of the evidence base of effective risk communication, 2) ready 
access to high quality evidence-based data in the form of information or decision support, 
and 3) clinical skills development.  
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Introduction 
 
Communicating the risks and benefits of treatments to patients is central to clinical practice 
in modern healthcare. It underpins informed consent and, arguably more importantly, 
creates the bridge between the evidence base for practice and effective decision making, 
particularly where decisions involve the patient [1 2]. Defined as the open two-way 
exchange of information between clinicians and patients on the risks and benefits of 
treatment, risk communication aims to facilitate better understanding and more informed 
decision-making [3 4]. The Cochrane Collaboration systematic review of effectiveness of 
patient decision aids (PtDAs) demonstrates that patients with access to such aids have 
improved risk perception [5 6]. Furthermore, The International Patient Decision Aid 
Standards (IPDAS) collaboration has included risk presentation as a core quality standard 
for PtDAs [7].  
 
The evidence base for ‘good’ risk communication has generated discussion and 
critique. Issues raised include practice variation arising as a result of geographical 
location, professional specialisation, statistical literacy [8] and personal characteristics 
and values [9]. Understandings of risk and uncertainty can vary [9 10], with lay 
interpretations tending to be subjective compared to clinical presentations of 
population–based risk. Patient understandings of risk are prone to subjective 
interpretations which can vary from person to person and differ from clinician 
presentations of population-based risk based on scientific rationality [11 12]. Emotions 
too can play an important role in risk communication [13 14], which in turn is 
influenced by features of the clinical encounter [15]. Research involving trials and tests 
of probabilistic risk formats together with theory-building are limited [16]. 
Nevertheless, some established principles exist to enhance clarity [16 17] and strategies 
have been developed to better help patients understand risks [18-20]. These include 
consistency in the use of numeric formats and a clear reference class. The use of 
absolute risks, natural frequencies and consistent denominators is helpful, whilst use of 
relative risks has the potential to confuse rather than enlighten [16 17 21]. The use of 
pictographs (or icon arrays) has a growing evidence base for effectiveness [22]. 
 
Thrombolysis with recombinant tissue plasminogen activator (rtPA) is an effective early 
treatment for ischaemic stroke which must be given as soon as possible within a limited 
time window (up to four and a half hours) from onset of symptoms [23 24].  However there 
are risks of bleeding, particularly symptomatic intracranial haemorrhage (SICH), which 
may lead to a worse outcome, including death, than might have occurred without treatment 
[25 26]. For clinicians, communicating risks and benefits to patients in this acute setting is 
complicated by the short time for decision making. Furthermore, stroke can manifest itself 
in a range of ways that are physically debilitating and mentally incapacitating, and may be 
disturbing to patients and their family [27 28]. An interview study with patients after stroke 
has shown that patients have limited perceptions of the risks associated with thrombolysis 
[29]. 
 
To date, this is the only primary in depth research with clinicians exploring risk 
communication in the context of a medical emergency. We describe doctors’ reported 
approaches to risk communication about stroke thrombolysis in the complex setting of 
hyper-acute stroke, and discuss their implications. 
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Methods 
 
Semi-structured interviews were conducted with thirteen doctors (ten stroke consultants 
and one registrar, and two emergency physicians – see Table 1) from three acute stroke 
units that were study sites in a programme of research into hyper-acute stroke services 
[28]. The doctors were purposively sampled with respect to their involvement in 
decision making and/or information provision about thrombolysis with specific 
reference to involvement of patients and carers in decision making. Interviews lasted 
between thirty and sixty minutes. The topic guide (see Supplementary Box 1) was 
developed according to the aims of the research protocol and a literature review, and 
included questions about participants’ attitude towards patient engagement, and the 
benefits and challenges of involving patients and carers in decision making and consent. 
 
Table 1: Clinicians across sites 
 
  Site A  Site B  Site C  Totals 
Stroke Consultant  4  2  4  10 
Registrar      1  1 
Emergency Medicine  
Consultant 
 2      2 
TOTALS  8  7  9  13 
 
 
Clinician interviews conducted by DBW and MLSL were audio-recorded and 
transcribed verbatim. A five stage process of analysis was adopted involving: 
familiarisation with the data through reading and rereading the transcripts for recurrent 
themes; identification of a thematic framework based on the objectives of the research; 
a process of indexing in which transcripts were annotated with codes derived from the 
thematic framework; and both summarising and synthesising the data into charts that 
used representative quotes to demonstrate themes [30]. NVIVO data management 
software was used, and the findings were interrogated and validated in data clinics 
attended by MM, DBW, KNJ, JM and MLSL. For a clinical perspective and to counter 
the fragmentation and de-contextualisation of the data through the coding process [31], 
individual interviews were read in full by RT.  
 
The sites 
 
Of the three sites in our study, Site C had been one of the pioneer research centres for 
thrombolysis for more than ten years. Clinicians at Site C did not routinely use 
standardised risk estimates to quote to patients. Sites A and B, serving a large rural area 
as well as urban and suburban conurbations, had recently started to offer thrombolysis. 
A standardised protocol had been developed to support the delivery of their 
thrombolysis service. Their service included some provision of telemedicine services, 
with Emergency Medicine consultants referring to stroke consultants remotely for 
advice on whether to offer thrombolysis. The protocol included a standard script on the 
risks and benefits of treatment for Emergency Medicine doctors to use with patients.  
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Results  
 
The overall data analysis of the clinician interviews generated a total of three themes 
and 17 subthemes. The results related to risk communication were drawn from the 
following themes (and subthemes): clinician perspectives (difficulties professionals 
face; patient and carer responses); going about decision-making (capacity and consent; 
risk communication); and contextual features (acute stroke management). 
 
 
Understanding the problem 
 
Table 2: Understanding the problem: 
The problem of disease complexity 
1a. diagnosing stroke is not as easy as diagnosing MI, there’s a lot of, yeah it’s a bit 
more tricky diagnosis (DocA01) 
1b. I think again that’s one difference in the areas of a stroke and heart attacks, a heart 
attack yes you do have severe heart attacks and milder heart attacks but, um, in a 
way there seems to be less variation compared to stroke. (DocB01) 
1c. There’s a similarity except with a stroke it’s a higher risk treatment.  There’s a 
slightly greater risk of side-effects and you know nasty complications (DocA05) 
1d. Yeah, you have to give them some idea of what lies ahead. Again that's difficult 
because some people will get worse, some people spontaneously do get better and 
[you] even occasionally get caught out and that person who has a very severe 
stroke actually does really well. But again you don't know that and you have to give 
people an idea of what the impact is without the treatment (DocB01) 
1e. I am trying to help people accept that there may be some risks involved in that. But I 
am not playing those up in all honesty. Because it seems to be from people’s 
reactions that they, they immediately, that eh, particularly families focus on that 
immediately (DocA03) 
1f. It was just coming up to 3 hours and err, I told the family that there was a risk of 
bleeding, he was at higher risk of bleeding because em because he had diabetes and 
whatever it was, his blood pressure was a bit high but he was going to be  ... from 
this stroke and err they were very keen to do anything they can.  So he actually got, 
I told them about risk of bleeding and despite the fact that 2 CTs […] which showed 
that he didn’t have any bleeding at all actually he just took a massive brain swelling.  
When he died the family turned around and said that we had killed him basically. 
(DocC08) 
The problem of communication: capacity and time 
2a. ….depending on what else is happening with them. You don’t know whether they’re 
completely taking the information on board. (DocA01) 
2b. Erm, the fact that people weren't expecting this to happen, are very shocked and 
erm, sometimes can't really appreciate that you're saying that they've had a stroke 
and they're at the moment severely disabled from it. Um, er hey they've got no 
experience of what a stroke is.  Most people tend to associate strokes with death 
shortly afterwards (DocB01) 
2c. you’ve just given them this whole raft of information about risks and possible side-
effects and this could happen and that could happen and you’re almost pushing 
them into a decision …because you know you’re under time pressure (DocA05) 
2d. so in the context of thrombolysis you do actually have to say,  we really can’t wait 
for that amount of time  do you actually do something  so, you are pressurising the 
patient but you have to be honest about that (DocA07) 
The problem of communicating quality of life after stroke 
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3a. I would say for example, the sort of construct we’ve had is particularly if you get a 
younger patient say who’s a musician or uses their hands at work and they’ve got a, 
if they get even a mild stroke with a [ ] function they probably won’t work again 
(DocA02) 
3b. You have to put it into the context of whether people are actually, you know, going 
to be in their own homes, are they going to be able to look after themselves or are 
they going to require a nursing home, making them more dependent on others, you 
have to put it into that context rather than simply saying well their leg might not 
get better (DocB01) 
3c. Um, and then obviously if they've had something affecting their speech and that's 
all it is then you, you, you would then focus very much on the impact of the speech, 
but again that's tricky because then you're saying well, you know, how important do 
you think it would be to them to be um, er, um exposed to the risk of this treatment 
for the benefit of being able to talk better?  Um, um so with more individual specific 
impairments it is a bit trickier (DocB01)  
 
The problem of disease complexity 
Clinicians interviewed were very aware of the challenges of risk communication in the 
hyper-acute setting. Describing disease presentation, they gave accounts of borderline 
cases where balancing risks and benefits might be difficult for them, let alone the 
patients. Symptoms may fluctuate over the course of the time window for treatment, 
adding additional uncertainty. Older patients often suffer multiple co-morbidities and 
there were those who presented with no clear onset time. These factors complicated 
diagnosis, risk communication and informed consent. This heterogeneity of 
presentation further explains why thrombolysis in acute stroke is unique in contrast, for 
example, to that in acute myocardial infarction (see Table 2, 1a and b). Clinicians also 
referred to the higher risk of adverse effects of thrombolysis in stroke patients than in 
patients with MI (see Table 2, 1c).  
 
Because of the nature of stroke, doctors reported facing challenges in predicting the 
likely outcome with thrombolysis for individual patients, given the probabilistic nature 
of treatment effectiveness (see Table 2, 1d and 1e). Even when the risks were explained 
and there is consent to treatment, serious adverse effects are difficult to accept (see 
Table 2, 1f). This element of uncertainty with regards to advice to individual patients 
presents challenges in communicating the probabilistic nature of risk.  
The problem of communication: capacity and time 
Clinicians highlighted the challenges of communicating with patients with limited 
capacity due to the stroke itself or existing co-morbidities such as speech and hearing 
impairments (see Table 2, 2a). They have to be alert to exactly how the stroke has 
affected the patient, particularly in terms of their ability to understand as well as to 
communicate. 
 
Clinicians also recognised that there was an added layer of emotional response to the 
acute and often unpredicted stroke. Many patients associated stroke with mortality, 
therefore bringing with it a heightened sense of alarm. Several clinicians described the 
typical scenario they encountered with patients (see Table 2, 2b). 
 
Participants also reflected on being pressed for time to deliver effective therapy. After 
a CT scan to determine if the stroke is ischaemic, hence confirming eligibility, patients 
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were put under pressure to decide if they would consent to thrombolysis (see Table 2, 
2c and d). 
The problem of communicating quality of life after stroke 
In communicating risk, the issues that clinicians were concerned with went beyond risk 
and benefit based on categorical outcomes, to translating risk and benefit information 
into implications for the patient’s quality of life after stroke. This is complicated by the 
heterogeneous nature of stroke, not only in terms of its initial severity but also with 
reference to the patient’s health status preceding stroke, such as prior dependency. 
Furthermore, communication of risks and benefits needs to take account of what is 
important to the individual patient. For example, the implications of old upper limb 
impairments may be markedly different for a professional pianist and a retired woman 
(see Table 2, 3a). This and other contextual factors, such as living arrangements and 
the availability of family support, can have significant implications for the impact and 
importance of the likely outcome with and without treatment (see Table 2, 3b). 
Clinicians report difficulties taking account of the specific trade-offs between risk and 
benefit with respect to quality of life outcomes (see Table 2, 3c).  
 
Risk and benefit information provided by clinicians 
 
Table 3: Risk and benefit information provided by clinicians 
Variation and attempts at standardisation 
4a. And I think that a protocol, a tele-medicine protocol will end up simplifying yes or 
no. That’s not the model we’re going for, we have a very, very intensively consultant 
led service here (DocCO1) 
4b. That time we can probably, we can have protocols in place and things that are you 
know everything, everyone is going to be in the one place then it’s easy enough to 
say well em, the nurses do this, this and this when they come in and the doctor does 
this, this and this but because it’s now going here, there and everywhere you can’t 
really em, you’ve got three groups of doctors to try and educate and they change 
over every few months so it’s just impossible (DocC08) 
4c. I mean the risk would be that I mean that for example last night there was an 
infectious diseases registrar that was on call who I had never met before I think he 
was new to the hospital so I can’t imagine he had ever seen a patient, probably 
hadn’t seen a patient with a stroke for about three or four years much less 
thrombolysed one (DocC08) 
4d. I know currently that 100 people, em 30, 3 ratio is the one that most clinicians seem 
to be using but perhaps not using in a consistent manner. At least for us they don’t 
seem to be.  (DocC07) 
4e. I think there needs to be em, err a minimum standard, standardised information 
available based on what you believe is the right interpretation of the trial. We have 
to remember that this is based on em, err limited number of randomised trials ….. 
This is a particularly heterogeneous disease it cannot be applied to a single patient, 
I think the predictions em in model could be designed but again I don’t think it can 
be predicted for an individual group of pa-, individual patients so…(DocC07) 
4f. ....we believe these are the kind of risks and benefits but you know it cannot be 
predicted to the individual patient (DocC07) 
4g. we have got … a very good, very short, four line brief of these are the risks, these 
are the issues.  So, I feel content that I have got a good grounding in it, that I 
understand it but rather than blag the risk issue it is nice to have it there in front of 
me (DocA08) 
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4h. So between ourselves, between the consultants who are doing it, we have got 
standard information that we give and tailor according to the needs of the patient 
but we’re all quoting the same risks and benefits. Which is a good thing. (DocA02) 
Verbal and numerical variations 
5a. the figures are standard but I will tell them that the treatment, the treatment has 
been shown to be, to be beneficial in that it can dissolve the clot and it can reduce 
people’s chances of becoming disabled, of being disabled as a result of the stroke 
but as with all things there are potential complications and one of those 
complications is, is bleeding, deterioration at, of the stroke and even death, and I’ll 
give those quotes in percentages, I will give that quote both as a statement and 
followed by percentages because not everybody understands percentages and then 
again reinforcing that there potential benefits but there are potential complications 
(DocA02) 
5b. [I say:] So I need to explain to you what the risk and the benefits are. Now the 
benefit is, very difficult to express but it’s a matter of improving the survival a little 
bit but more importantly improving the recovery so that you’re less disabled as a 
result of this stroke, and the chances of that being beneficial to you is that if we 
treat a hundred people then thirty-two of them will benefit in this way. Now on the 
other hand the drug is quite dangerous, it can sometimes cause bleeding and 
sometimes can cause catastrophic bleeding leading anywhere including into the 
brain. So it could make the situation much worse but the chances of that occurring 
is if you treat a hundred people with this treatment about two or three will be 
harmed in that way. (DocC01) 
5c. I’d have a conversation along the lines of, you know, em, if we don’t do anything, 
you know, your chances of being dependent are this. If we give you thrombolysis, 
then an extra 14 or 16 people will be independent as a result of the stroke and there 
is a risk of x per cent and x per cent of bleeding. (DocA07) 
5d. there’s a few people who perhaps make a little bit of a recovery but not full and 
then, there’s no difference in the vast majority and then a very small minority who 
actually, you probably die as a result of the treatment at the end of the day. 
(DocB02) 
5e. Well what I tell them is that em, in terms of the benefit they’ve got first of all they, 
they’ve got roughly a thirty per cent or one third better chance of having a good 
outcome than if they don’t get treatment em, and that roughly one in between one 
in ten and one in twelve people will have a dramatic improvement you know with 
that sort of spectacular recovery but most, for most people that doesn’t happen eh, 
but for the rest you’re talking more has a thirty per cent better chance for getting 
them to a good outcome in other words being independent I explain that to them, 
em, you know and being able to do everything for themselves pretty much.  Em, and 
then tell them about the risk of haemorrhage and which in terms of symptomatic 
bleeding which is between sort of em three and five per cent but I usually explain 
that in terms of em, you know a one in em, a one in twenty risk rather than you 
know because people don’t tend to understand percentages (DocC08) 
5f. so I’ve tried various ways of describing that around em, you know the same 
proportion of people overall will die with or without this treatment it’s just that they 
tend to die of different things if they are given the treatment they tend to die of 
complications of the treatment rather than complications of the stroke, it doesn’t 
make any difference to the risk of dying overall but it does improve your chances if 
you survive of having a good outcome. (DocA03) 
 
Variation and attempts at standardisation 
Different stroke units adopted standardisation of risk data depending on how stroke 
services were organised. Site C, as a pioneer centre, depended less on standardised data 
as one clinician explained (see Table 3, 4a). But with the re-configuration of stroke 
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services due to major physical restructuring, another noted the challenge of junior or 
inexperienced doctors communicating risks and benefits (see Table 3, 4b and 4c).  
 
A clinician at Site C had undertaken an audit of his unit, and found that there was 
variation in the figures quoted by colleagues (see Table 3, 4d). Acknowledging the 
limits of trial data and difficulties in making predictions on individual cases because of 
the heterogeneity of stroke (see Table 3, 4e), he worked on producing a leaflet for 
patients. From his perspective, patients had the right to a minimum standard of 
information, but the limits of predictability also had to be made clear (see Table 3, 4f). 
He had drafted the following information:   
 
“Approximately 32 out of 100 (or 1 in 3) patients treated with ‘clot busting’ medication 
will benefit from the treatment. The treatment benefit means that the patient will be left 
less disabled than if not treated. One in every 10 patients may make a full recovery 
from stroke with no disability. On the other hand, 3 in every 100 patients treated will 
be ‘worse off’ because of treatment related side effects of bleeding in the brain.” (Site 
C draft leaflet for patients) 
 
In comparison, in the telemedicine context, clinicians at Site A referred to the following 
standardised script developed to support consistent communication as beneficial to their 
practice (see Table 3, 4g and 4h).  
 
 There is a risk that the treatment will cause bleeding in the brain, causing a 
worsening stroke.  This occurs in 7 out of 100 patients treated and is fatal in 2 
of these.  
 Despite this, overall the treatment is much more likely to help than to cause 
harm. 
 Without treatment of 100 people with a stroke, 26 will survive with minimal or 
no disability – with treatment of 100 people with a stroke, 40 will survive with 
minimal disability. 
  (Site A standard information used for quoting to patients) 
 
Verbal and numerical variations 
Individual doctors reported very different approaches to communication of risks and 
benefits of thrombolysis, and how these approaches varied. In the majority of cases, 
risk communication consisted of a verbal description of the treatment effect, and the 
chances of survival, disability and bleeding complications. These explanations of risk 
and benefit commonly comprised a mix of both words and numbers (see Table 3, 5a 
and 5b). There were however potential problems in the way words were used. In a report 
of what he said to patients (see Table 3, 5c), a clinician moved the referent in the 
sentence from the patient (‘you’) to stroke patients in general (‘people’) leading to 
potential ambiguity. Doctors also described the use of ‘elastic terminology’ such as ‘a 
little bit’ and ‘minority’ and ‘majority’ (see Table 3, 5d).  
  
The way that numerical data were presented varied quite markedly. Clinicians used a 
mix of absolute numbers, percentages, fractions, ratios and differing denominators (see 
Table 3, 5c and 5e); some clinicians believed that not all patients were comfortable with 
percentages (see Table 3, 5a and 5e). Clinicians expressed concern about presenting 
figures on overall benefit (i.e. overall reduction in dependency with no overall effect 
 10 
on mortality) alongside the risks of early bleed (including risk of early death from 
severe haemorrhage). These latter risks are incorporated within the data on overall 
benefit, but some clinicians clearly felt that the risks of treatment needed to be presented 
separately (see Table 3, 5f).  
 
Communication strategies adopted by clinicians 
 
Table 4: Communication strategies adopted by clinicians 
Adopting a phased approach 
6a. you start with basically saying you know ‘I think you’ve probably had a stroke’, you 
might give a little explanation as to what that is, well, most people don’t really 
know what a stroke is, they have some idea but maybe don’t understand it and then 
you start getting into the process and it’s probably, it’s round about then that you 
say ‘You know there is this treatment that is now available, this is how it works.  To 
do this we’re going to have to get a scan first, or we’re going to have to do that 
fairly quickly’ erm then you get them to the sort of scanning process, which in itself 
will take 15, 20 minutes and then you take it from there and again quite often we 
get to that stage and find that we can’t give thrombolysis because they’ve had a 
bleed rather than an ischemic type stroke. (DocA05) 
Being responsive to the patient and family 
7a. Erm, there's various levels of it potentially in terms of engagement because you've 
got those patients who want to know absolute all risks, benefits, down to, you 
know, um, proportions of this, chances of that happening but, erm, that data often 
isn't available in that level of detail and then you've got other patients who just say, 
well they're not that interested in risks and benefit, they just want to know, what 
you would do (DocB01) 
7b. I try to start general and broad and to see whether people are taking that 
information, you know, taking that information in, erm, and will give more, and I 
get, then go into more detailed information but adjust my language and detail 
according to how people are responding and you know their ability to take 
information at that time and their educational level.  (DocA02) 
7c. where the discussion is with the family on behalf of the patient then that is often 
more difficult eh, because families feel eh, eh, that, that, they’re anticipating a 
situation where the patient dies and where they feel that some of the, they’ve made 
a decision that’s led to that (DocA03) 
Checking and documenting information 
8a. you give them the information and you ask them to paraphrase it back to you so 
like you can always say to them can you explain to me what the benefits of the clot 
busting treatment are can you try to explain what I just said to you about the 
benefits of the clot busting treatment and I think a lot of the time they’re not have 
as clue as to what you’ve said to them even though we did put it in their notes in 
the most simplest language possible eh, so I already do that em, and obviously you 
would ask them what do you understand is the hazard of this treatment what do 
you understand is the benefit of it em (DocC08) 
8b. I mean I think everybody should be documenting what they’ve told the patient in 
terms of the risks because if the patient’s relatives then turn around and say well 
you didn’t tell us about that we say well actually I did and I wrote it in the notes 
what I said to you so em, the chances are they forget anyway but at least if you 
write it in the notes its …(DocCO8) 
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Adopting a phased approach 
One crucially important strategy that was reported in dealing with the challenge of time 
pressure was a phased approach to risk/benefit communication. Clinicians recognised 
that patients needed first to understand that they had had a stroke and what this meant. 
This prepares the patient for the definitive discussion of risks and benefits after the 
scan. This phased approach can take place all through the patient’s care pathway, 
contributing to the patient’s preparedness for making the final decision (see Table 4, 
6a). 
 
Being responsive to the patient and family 
Several clinicians believed being responsive to patient needs was very important, 
reporting that patients were not always comfortable with making decisions solely on 
the basis of numbers and did not always base their decision-making upon them (see 
Table 4, 7a). They adjusted their risk communication, for example by simplifying 
information or providing detail in stages, all the while modifying their language in an 
interactive way according to their perception of the individual patient’s needs or 
understanding (see Table 4, 7b). 
 
Doctors also perceived that patients often depended on their family members for 
decision-making support. Communicating risk to family members can be challenging 
where the patient lacks capacity, requiring sensitivity to family members’ positions of 
responsibility (see Table 4, 7c). 
 
Checking and documenting information 
One strategy that clinicians employed was to ask patients to recall in their own words 
what had been explained to them (see Table 4, 8a). As an additional safeguard, it was 
recommended that the information provided was documented (see Table 4, 8b).  
 
  
Discussion and conclusion 
 
Discussion 
 
Research into risk communication strategies in different healthcare contexts has yielded 
a range of results. While there is appreciation for personalised risk information in 
patients at risk of stroke and coronary heart disease, this did little to effect behaviour 
change [32], or to encourage attendance at screening tests [33]. In the context of clinical 
genetics [34], supportive counselling proved to be more effective than knowledge 
assimilation. Such contexts are very different to emergency or hyper-acute situations, 
where near on-the-spot decision-making requires optimum knowledge translation. A 
review of the literature found decision support interventions (DSIs) in emergency 
departments were associated with improved patient knowledge and satisfaction [35]. 
Discourse analysis of ‘risk talk’ conducted in varied health contexts such as antenatal 
and urology clinics has identified important contextual influences [11 15]. As 
highlighted in this study, these include specialist skills and time frames. But to date, no 
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such studies have been conducted on clinicians’ risk communication practices in the 
hyper-acute context of stroke.  
 
As a timely contribution to this body of evidence, our interview study of clinicians 
involved in communicating the risks and benefits of thrombolysis in the hyper acute 
stroke setting has detailed the complexity and challenges involved. These include 
disease complexity, patient capacity and time pressure, and quality of life issues. 
Importantly, clinicians were taking account of patients’ health status both prior to, and 
as a result of, their stroke. Explanations of past and predicted health state, and the 
potential impact on quality of life, are an important corollary to risk communication 
because they enable the potential impacts of treatment to be seen in the wider context.  
Clinicians thought deeply about the challenges of good risk communication in this 
complex, hyper-acute setting and used a range of approaches to address them. They 
communicated risks and benefits orally in a variety of formats i.e. both verbal and 
numerical, and often used a mix of absolute numbers, percentages, fractions and odds 
ratios. Unfortunately, approaches such as percentages which do not refer to the base 
rate or reference class (e.g. patients of the same age group) have been found less 
effective in communicating risk [16].  
 
 
The variation reported in clinicians’ risk communication, alongside the role of non-
stroke specialists in communicating with patients, suggests that there is potential value 
in standardised risk and benefit information. At the same time, there is a tension 
between standardisation and the appropriate personalisation of risk communication. 
The need for flexibility and creativity in communicating risk was also reported, 
including adapting the communication to the particular circumstances of the individual 
patient as far as possible. Clinicians were concerned that a standard summary of 
aggregated trial-derived data may not apply to individual patients whose clinical 
characteristics might make them more or less likely to suffer an intra-cerebral bleed, 
for example. Ideally, we would have mechanisms of personalising risk and benefit 
based on patient characteristics, but this is only rarely available in a form that supports 
such personalisation [1 36].  
 
Clinicians employed various strategies in their risk communication, varying and 
tailoring their approach in response to cues from the individual patient and/or family. 
Other reported strategies were to check that risks and benefits were understood and to 
document information. More importantly, clinicians were phasing the transfer of 
information over the care pathway, as studies of clinicians in other contexts have found 
[37]. Thus, our study has identified in detail the specific problems related to risk 
communication in the hyper-acute context of stroke, points to possible solutions and 
invites clinicians to reflect on their current practice. 
 
 
Limitations 
 
The limitations of the research are common to qualitative research in general. These 
include the small purposive sample size and geographical distribution, thus affecting 
the generalizability of the findings, the applicability of which depends on regional 
stroke management protocols. An accepted limitation of the research method is its 
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reliance on participants’ self-reported experiences and views rather than actual 
recordings of clinician-patient interactions, which in an emergency context could have 
ethical implications. The interviews were conducted by two different researchers with 
different backgrounds (geography and sociology) but the data was interrogated by 
several researchers, contributing to data validation. In addition, an artefact of the 
interview process arises from clinicians’ assumptions of what is expected from them in 
the interview, which may have influenced their reported accounts. Nevertheless, there 
were corroborations in the findings from patient interviews [28].  
 
Conclusion 
 
Risk communication about thrombolysis is one of those medical interactions in which 
complex uncertainties are involved. The human element in responding to such 
uncertainty results in practice variation because of the influence of institutional 
contexts, personal characteristics and values, and lay perceptions of risk. Added to this 
is the impact of professional specialisation, competence and accountability. In this 
paper, we elucidate the challenges of effective risk communication in a hyper acute 
setting and identify the issues regarding variation in risk communication and the use of 
less effective methods for risk communication such as the use of elastic terminology, 
percentages and a mix of numerical formats that can be potentially confusing to 
patients. We provide examples of good practice such as the phased transfer of 
information over the care pathway and being responsive to the patient and family, and 
identify ways in which clinicians might be supported to overcome challenges. This 
includes standardised risk and benefit information alongside appropriate 
personalisation of risk communication. Thus the findings of this study point to the value 
of risk communication training for stroke clinicians, and standardised information, 
particularly for non-stroke specialists and for less experienced clinicians working in the 
hyper-acute context of stroke. The complexity in risk communication highlighted in 
this study and the literature points to the need for further research that includes 
randomised controlled studies of decision support tools, and the development and 
application of more theoretically-oriented perspectives [8 9 16].  
 
Practice implications 
 
Examples of good practice uncovered by the study include clinicians’ attention to: the 
needs of the individual patient; his or her pre-stroke life and quality of life issues; and 
the phased transfer of information. However, the identified variations in risk 
communication might be expected to adversely affect understanding by patients and 
their families. This is by no means unique to the setting of thrombolysis, but arguably 
in the time constrained setting, the study has clearly shown that there is particular 
potential for greater appreciation of the evidence base for effective risk communication 
and for enhancing clinicians’ skills in risk communication. Such communication is 
likely to depend upon accessibility of up-to-date, consistent and reliable data presented 
in a form that promotes effective communication. As in other emergency settings [35], 
ready access to high quality evidence-based data in the form of information or decision 
support, alongside skills development, would be likely to improve risk communication.  
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In other clinical settings, individualisation or subgroup presentation of data has proven 
helpful [1 2 36], but this is not without its challenges. Likewise, there are questions to 
be asked about how the standardisation of risk communication in hyper-acute stroke 
might affect decision making and about how it would be possible to introduce a level 
of standardisation without losing the important context dependent and adaptive nature 
of current (reported) practice, translated to individual level information for the patient. 
Training in terms of using more appropriate and effective formats for the 
communication of numerical risks and benefits is also recommended. 
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